Skip to Content

Our Financial & Valuation Services

Need to align, to clarify, to decide? 

Looking to be challenged? Seeking a second pair of eyes?

Have to account / report at Fair Value? 


Whatever your prime motive, we have the solution.

Corporate Governance

Good Corporate Governance 

Valuation and Fairness Opinion for internal or external purposes

As an appraiser specializing in IP-driven, Life Sciences and High Growth / High Risk and ventures, we understand the unique challenges in this dynamic, complex, and at times counter-intuitive field. 

 We provide independent, context-specific, and data-driven insights to support strategic decision making, ensuring governance remains transparent and effective.

 We support younger ventures in their transition to good governance, helping them understand the importance of shifting from a founder-centric model to a decision making environment that requires alignment between management, the board, and shareholders.

Sparring partner and sense-check

Generating Optionality 

Sparring Partner, Deep Analysis and Sense-Check in Financing / BD&L / M&A situations

In High Growth / High Risk, increasing the odds of success means staying sharply focused to augment readiness—while still being able to catch two (or maybe three) birds with one stone. That’s where strategic flexibility comes in: the ability to pivot, capitalize, mitigate and realize value quickly as events unfold.

By generating optionality, management can present a range of well-prepared, coherent strategies to the board and shareholders—instilling confidence that the company is positioned to adapt, thrive, and create value in uncertain or evolving environments.

 We work in context, ensuring narrative coherence and identifying vulnerabilities and leverages to enhance a position in negotiation

 We especially anticipate on how deals are operationalized afterwards, ensuring smooth execution and sustained value realization. 

Accounting Reporting

Accounting and Sanity-check

Fair Value, tailored-to-need modeling and independent review 

Innovative Life Sciences companies—and their auditors—face a layer of complexity rarely seen in other industries.  

The primary challenge lies in accurately reflecting the value, amortization, impairment, and risk profile of IP-related assets, as well as contracts involving licensing, earn-outs, complex financing, or share-based payments.

 We provide on-demand modeling and notes tailored to specific accounting needs of privately-held as much as listed companies.

 Additionally, we review and conduct thorough sanity checks on models, assumptions and valuation matters, whether created internally by our customers or their providers, to support internal controls, audit readiness and SOX compliance.